Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss
Pleural and Pericardial Effusions Associated with Semaglutide: A Case Report [PMID: 41666880] Laboratory literature summary: Pleural and Pericardial Effusions Associated with Semaglutide: A Case Report
Establishment of K7M2-Luc orthotopic osteosarcoma mouse model and therapeutic effect evaluation Tumor model establishment To establish orthotopic model, K7M2 cells (3 10 6 cells/well) were dispersed in PBS buffer and implanted into right tibia of BALB/c mice
3400931710509 Ce produit n'est plus en stock Attention : dernires pices disponibles
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 23.98
US$ 28.23
US$ 25.47
